Revista Paulista de Pediatria
Basic information
The Revista Paulista de Pediatria RPPed is an annual publication of Sociedade de Pediatria de São Paulo (SPSP, acronyms in Portuguese). Since 1982, it has been dedicated to publishing original articles, reviews and clinical case reports in the area of health promotion for newborns, infants, children and adolescents, with an emphasis on the publication of clinical and epidemiological studies. The objective is to disseminate research of methodological quality related to topics of interest. The articles are available in full in electronic format and open access. The Journal is indexed in the databases Web of Science, Pubmed Central, Medline, Scopus, Embase (Excerpta Medica Database), SciELO (Scientific Electronic Library Online), LILACS (Literatura Latino-Americana e do Caribe em Ciências da Saúde), Index Medicus Latino-Americano (IMLA), Sumários de Revistas Brasileiras, Redalyc (Red de Revistas Científicas de América Latina y el Caribe, España y Portugal Scientific Information System) and DOAJ (Directory of Open Access Journals). The abbreviation of its title is Rev Paul Pediatr, which should be used in bibliographies, footnotes and bibliographic references. |
Open Access
This journal follows the Open Access model, allowing unrestricted virtual access (including no financial barriers) to all scientific texts published by the journal. Open Access is a condition whereby the copyright holder of an academic work grants usage rights to third parties through an open license (Creative Commons Attribution, CC-BY), permitting immediate free access to the work and authorizing any user to read, download, copy, distribute, print, search, or link to the full texts of the articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose. |
Open Science Compliance
Following the guidelines of the global Open Science movement, RPPed adopts practices with the aim of contributing to open and shared scientific knowledge for the scientific community in different countries and for society. The published manuscripts are freely accessible in indexing databases and published on social networks and the Associação de Pediatria de São Paulo website. In published works, the contributions of each author to the study are indicated and some form of sharing of the database of original studies is mandatory. Furthermore, in line with Open Science, RPPed suggests publishing the study with the name of the reviewers responsible for its review, as long as these reviewers authorize the publication of their name when filling out the Review Form. Reviewers have the option to report review activity on Publons. Executive editors authorize the publication of their names alongside articles edited by them. |
Publication Ethics
RPPed adopts and uses the guidelines of the SciELO Guide to Good Practices for Strengthening Ethics in Scientific Publication. The ethical stance of research is essential for RPPed, therefore, misconduct, for example, plagiarism, is evaluated by the editorial board seriously and rigorously. Clinical trials are only accepted upon presentation of a registration number and registration basis, following the clinical trials regulations of ORDINANCE No. 1,345, OF JULY 2, 2008, Ministry of Health of Brazil. To register, access: https://ensaiosclinicos.gov.br/ Information regarding support for policies for registering clinical trials: According to ANVISA resolution - RDC 36, of June 27, 2012, which amends RDC 39/2008, all clinical studies phases I, II, III and IV must present proof registration of clinical research in the Brazilian Registry of Clinical Trials (ReBEC) database, a registry managed by the Fundação Oswaldo Cruz of clinical studies on human beings, publicly or privately funded, conducted in Brazil. The Brazilian Clinical Trials Registry (ReBEC) number must appear on the title page in parentheses “(The clinical case registration number is: -website)”. For cases prior to June 2012, proof of other primary records from the International Clinical Trials Registration Platform (ICTRP/WHO) will be accepted. Research involving humans must be approved by the Research Ethics Committee and the CAAE number must be placed on the Title Page.
Systematic reviews submitted from August 2021 must be registered on the PROSPERO platform (International Prospective Register of Systematic reviews). The record number must be included in the summary in the Data source section. |
Focus and Scope
The Revista Paulista de Pediatria is intended for the publication of original articles, reviews and clinical case reports in the area of health promotion for newborns, infants, children and adolescents, with an emphasis on the publication of clinical and epidemiological studies. The objective is to disseminate research of methodological quality related to topics of interest. |
Digital Preservation
| This Journal follows the standards defined in the SciELO Program's Digital Preservation Policy program. |
Indexing Sources
Bibliographical Sheet
|
Websites and Social Media
Preprints
The Journal encourages the publication of preprint articles on public platforms, such as Preprints, SciELO Preprints and others, so that, if applicable, they can be discussed openly before being published. RPPed, in relation to preprints, points out that it does not consider that the publication of articles in preprint repositories takes away the originality of the submitted article. When submitting articles deposited on public preprint platforms, it is necessary to send preprint identification data to maintain information transparency:
|
Peer Review Process
RPPed adopts a rigorous and transparent peer review process, based on the principles of impartiality, confidentiality, and scientific rigor, with the aim of ensuring the quality and integrity of the articles published. The process is conducted by the editorial board at its different levels (editor-in-chief, associate editors, executive editors, and reviewers) and comprises the following stages:
In accordance with Open Science, RPPed publishes, in the final article, the names of the editors responsible for the evaluation. |
Open Data
RPPed encourages the author(s) to publish access to the analysis data repository or the data to be made available with the corresponding author, in this way the accessibility of the relevant data will be ensured. The Guide's guidance for promoting openness, transparency and reproducibility of research published by SciELO journals is followed by RPPed, aiming to contribute to the integrity of scientific research. Submitted articles must be accompanied by the Open Science Compliance Form duly completed and attached to the mandatory documents. |
Fee Collection
RPPed does not charge any fees for evaluation and publication. The publication is free and open access. The maintenance of the Journal is entirely paid for by the Associação de Pediatria de São Paulo. Only the mandatory submission of articles in English is the responsibility of the authors, with no costs incurred by RPPed. |
Ethics and Misconduct Policy, Errata and Retraction
The ethical stance of research is essential for RPPed, therefore, misconduct, for example, plagiarism, data tampering, duplication of publications, undeclared conflict of interest, among others, is evaluated by the editorial board seriously and rigorously. In confirmed cases of misconduct, RPPed reserves the right to reject the manuscript, in addition to communicating the infraction to affiliated institutions and even prohibiting future submissions by authors to the Journal.
|
Conflict of Interest Policy
In the case of a conflict of interest, everyone involved in evaluating the manuscript is obliged to declare the conflict. The conflict of interest may be of a personal, commercial, political, academic or financial nature. Conflicts of interest may occur when authors, reviewers or editors have interests that may influence the preparation or evaluation of manuscripts. When submitting the manuscript, authors are responsible for recognizing and disclosing financial or other conflicts that may have influenced the work. If there is, even potentially, a conflict of interest, the author(s) must inform this in a signed document attached to the submission platform. The existence of a conflict of interest does not prevent the publication of an article, but it is essential for the evaluation to be transparent, in possession of all information about the article. Authors: authors must declare the conflict of interest in the ScholarOne submission system and on the article's Title Page. If there is no conflict of interest, enter - Conflict of Interest: nothing to declare. Reviewers and editors: must inform the RPPed secretariat or the editor-in-chief of any possible conflict of interest. Communication must occur before the assessment begins. |
Adoption of Similarity Checking Software
RPPed makes use of CrossRef software to detect similarity. Manuscripts with similarity above 35% between different sources or 10% from a single source are rejected, unless the similarity is with theses deposited on institutions' platforms to obtain an academic level. All articles are checked immediately after submission, before peer review. The similarity assessment is done by the editor-in-chief. If similarity is detected, the authors are notified and the article is rejected. RPPed does not allow the use of AI (Artificial Intelligence) in the preparation of manuscripts. |
Adoption of software using Artificial Intelligence resources
RPPed allows the use of artificial intelligence (AI) tools to support manuscript preparation, including writing assistance, language revision, translation, programming, organization of computational routines, and exploratory data analysis, as recommended by the International Committee of Medical Journal Editors (ICMJE). The use of these tools must be ethical and transparent, under the direct supervision of the authors. AI tools cannot be listed as authors or coauthors because they do not meet authorship criteria, cannot take responsibility for the content, and cannot be accountable for conflicts of interest, copyright, data integrity, or approval of the final manuscript version. When AI tools are used, authors must explicitly declare this use in the submission letter, on the title page, and in the manuscript itself, in the Method or Acknowledgments section. The declaration must state which tool was used, its purpose, and the stage of the work in which it was employed. Authors remain fully responsible for the accuracy, originality, scientific integrity, interpretation of results, appropriateness of references, and ethical compliance of all submitted content, including excerpts, images, codes, analyses, or translations produced with the support of AI tools. Content generated or modified by AI must be carefully reviewed, verified, and edited by the authors before submission. |
Sex and Gender Issues
The RPPed editorial team, in addition to the authors who publish in the Journal, always seek to observe the guidelines on Sex and Gender Equity in Research – SAGER. The SAGER guidelines comprise a set of guidelines for reporting information about sex and gender in study design, data analysis and results, and interpretation of findings. Furthermore, RPPed observes the gender equity policy in the formation of its editorial board. |
Ethics Committee
Authors must attach a statement of approval from the Research Ethics Committee of the institution responsible for approving the research. Clinical trials will only be accepted upon presentation of a registration number and registration basis, following the clinical trials regulations of ORDINANCE No. 1,345, OF JULY 2, 2008, Ministry of Health of Brazil. To register, access: http://www.ensaiosclinicos.gov.br/ Research involving human beings must be approved by the Research Ethics Committee and the CAAE number must be placed on the Title Page.
Systematic reviews, submitted from August 2021 onwards, must be registered on the PROSPERO platform (International Prospective Register of Systematic reviews). The record number must be included in the summary in the Data source section. |
Copyright
Authors of articles published by Revista Paulista de Pediatria maintain the copyright of their works, licensing them under the Creative Commons Attribution CC-BY license, which allows articles to be reused and distributed without restriction, as long as the original work is correctly cited. The authors grant Revista Paulista de Pediatria the right of first publication. |
Intellectual property
All Journal content, except where otherwise identified, is licensed under a Creative Commons Attribution BY License. The articles are available, in their electronic format, in full in English, through open and free access in the indexing databases. Author's responsibility The author's declaration of responsibility in the submission letter regarding the content published in the Journal must be attached as a mandatory supplementary document. The subjects, data and concepts published in RPPed are the sole responsibility of the authors. Authors of articles published by RPPed maintain the copyright of their works, licensing them under the Creative Commons Attribution license, which allows articles to be reused and distributed without restriction, as long as the original work is correctly cited. Revista Paulista de Pediatria encourages authors to self-archive their accepted manuscripts, publishing them on personal blogs, institutional repositories and academic social media, as well as posting them on their personal social media, as long as the full citation is included in the website version of the Journal. |
Sponsors
The publication receives exclusive funding from Associação de Pediatria de São Paulo (Sociedade de Pediatria de São Paulo - SPSP). |
Editor in chief
|
Associated Editors
|
Executive editors
|
Emeritus Editor
|
Editorial Council
|
Editorial production
 |
Types of documents accepted
TYPES OF ARTICLES PUBLISHED Original articles: mainly include epidemiological and clinical studies. Non-clinical studies may be accepted, but they are not the main focus of the Journal. Case reports: include articles that describe cases of patients with rare diseases or infrequent or innovative interventions. Review articles: systematic or scoping reviews of the literature on a selected topic. RPPed prioritizes systematic reviews, especially those including meta-analysis. Narrative, integrative, or non-systematic reviews will only be considered when requested by editorial invitation or when the authors provide, in the submission letter, an explicit justification of a methodological gap that prevents or makes a systematic review unsuitable. Editorials: commissioned by the editors to discuss a controversial and/or interesting and/or relevant topic or original article to be published in RPPed. |
Author Contribution
All articles must describe, on the title page, the contribution of each author using the CRediT taxonomy. Only the roles actually performed by each author should be indicated, using the following nomenclature:
All authors must have made a significant contribution to the preparation of the article, meet the authorship criteria of the International Committee of Medical Journal Editors (ICMJE), and approve the final submitted version. The declared contributions will be mentioned in the published article. The indication of contributions must be specific for each author and does not replace collective responsibility for the integrity of the manuscript. |
Form and preparation of manuscripts
The complete content of the original article must comply with the “Uniform Requirements for Originals Submitted to Biomedical Journals”, published by the International Committee of Medical Journal Editors. Each of the following sections must start on a new page: summary and keywords, in English and Portuguese; text and bibliographic references. Tables and figures must be numbered in Arabic numerals and placed at the end of the text. Each table and/or figure must contain a title and footnotes. Article submission format ATTENTION: Each of the items below must be uploaded separately to the system:
EQUATOR Checklists Manuscript submission to RPPed must include the reporting checklist appropriate to the study design, according to EQUATOR Network guidelines. The checklist must be completed by the authors and submitted as a separate file, indicating the manuscript pages or sections where each item was addressed. The main applicable checklists include CONSORT for randomized clinical trials, STROBE for observational studies, PRISMA for systematic reviews and meta-analyses, PRISMA-ScR for scoping reviews, CARE for case reports, STARD for diagnostic accuracy studies, CHERRIES for online surveys, RECORD for observational studies using routinely collected secondary data, TRIPOD for prediction models, SQUIRE for quality improvement studies, CHEERS for economic evaluations, ARRIVE for animal studies, and SRQR or COREQ for qualitative studies. When specific guidelines or extensions are relevant to the study design, they should also be used. Failure to submit the mandatory checklist may result in the manuscript being returned to the authors before editorial evaluation begins. Submission of the checklist does not replace the need for a complete, clear, and transparent description of the methods, results, and limitations of the study in the manuscript body. Participant flow diagram The submission must include a participant flow diagram as a mandatory figure for clinical trials, cohort studies, and case-control studies. The flow diagram should present, as applicable to the study design, the number of individuals assessed for eligibility, excluded, and the reasons for exclusion, included, allocated or classified into groups, followed up, lost to follow-up, excluded from analyses, and effectively analyzed. For clinical trials, the flow diagram should follow the CONSORT structure. For observational studies, including cohort and case-control studies, the flow diagram should be compatible with STROBE recommendations and allow clear understanding of sample formation and any losses, exclusions, or missing data. When the flow diagram is not applicable, authors must justify this decision in the submission letter. Data Availability Statement All manuscripts submitted to RPPed must include a Data Availability Statement on the title page. The statement must clearly and verifiably indicate where and how the data supporting the results presented can be accessed, including original data, secondary data, codes, analytical materials, and metadata, when applicable. The statement must follow one of the following modalities: data publicly available in a repository, with identification of the repository and a persistent identifier, when available; data available upon justified request to the corresponding author, with the conditions of access specified; or impossibility of data sharing, with an objective justification based on ethical, legal, contractual, institutional, or confidentiality restrictions. Whenever possible, RPPed recommends that data be deposited in recognized, publicly accessible repositories capable of assigning persistent identifiers, such as Zenodo, Figshare, Open Science Framework (OSF) and SciELO Data. Sharing must comply with applicable legislation, research ethics standards, protection of personal data, and commitments made to participants, institutions, and funders. Absence of the Data Availability Statement, or submission of a vague or incomplete statement, may result in the manuscript being returned before editorial evaluation begins. The statement does not replace the need for a complete description of methods, analytical procedures, and data-handling criteria in the manuscript body. Study registration Clinical trials must be prospectively registered in a recognized public platform before inclusion of the first participant. For observational studies, prospective cohorts, implementation studies, quasi-experimental studies, and other designs with hypotheses, outcomes, or analytical plans defined in advance, RPPed recommends, whenever possible, prospective protocol registration, preferably before data collection, participant recruitment, or data analysis begins. Records in recognized and publicly accessible platforms will be accepted, including Registro Brasileiro de Ensaios Clínicos (ReBEC), ClinicalTrials.gov, ISRCTN Registry, Open Science Framework (OSF), and other platforms appropriate to the study design. For systematic reviews, registration in PROSPERO or another appropriate repository is mandatory when the study does not meet PROSPERO eligibility criteria. When registration exists, the manuscript must inform, on the title page and in the Method section, the platform name, registration number or identifier, and registration date. Relevant differences between the registered protocol and the submitted study must be described and justified in the manuscript. TITLE PAGE Format with the following items:
ABSTRACT (ENGLISH) AND RESUMO (PORTUGUÊS) It must be in English and Portuguese, with a maximum of 250 words. Do not use abbreviations. It must be structured according to the following guidelines:
For the abstract, it is important to follow the rules of English grammar. For the resumo, Brazilian Portuguese grammar should be followed. KEYWORDS AND DESCRITORES They must be in English and Portuguese, respectively. Provide 3 to 6 descritores/keywords below the abstract/resumo to help ensure the appropriate inclusion of the abstract in bibliographic databases. Exclusively use descritores/keywords from the list of “Health Sciences Descriptors” prepared by BIREME and available on the website https://decs.bvsalud.org/en/. This list shows the corresponding terms in Portuguese and English. TEXT It is important to obey grammatical rules and maintain fluency in the English.
GENERAL RULES Submissions must be made in English only. The article must be typed in A4 format (210x297mm), with a 25mm margin on all margins, double spaced in all sections. Use Times New Roman font size 11, numbered pages in the upper right corner and Microsoft Word® word processor. Manuscripts must contain, at most:
It is mandatory to send a submission letter signed by all authors. In this letter, authors must mention that the article is original, has never been published and has not been or will not be sent to another journal while its publication is being considered by RPPed. Furthermore, the letter must state what role each author played in preparing the study and article and that everyone agrees with the version sent for publication. The letter must also mention that no information was omitted regarding funding for the research or connections with people or companies that may be interested in the data covered by the article or case. Finally, it must contain an indication that the authors are responsible for the content of the manuscript. Main reasons for immediate rejection RPPed may reject or immediately return, before peer review begins, manuscripts that do not meet essential editorial, ethical, methodological, or scope requirements. The main reasons include:
Immediate rejection does not prevent resubmission, provided that the authors fully correct the pending issues and meet the current RPPed requirements. Textual similarity policy RPPed may use textual similarity detection tools as part of editorial evaluation. Similarity reports will be analyzed qualitatively and contextually, and there will be no automatic rejection based exclusively on global similarity percentages or similarity with a single source. The editorial decision will consider the nature, extent, and location of similar passages, as well as adequate citation, originality of the research question, data, analyses, and interpretation of results. High similarity in methodological sections, standardized descriptions of instruments, statistical procedures, previously registered protocols, theses, dissertations, preprints, or other materials previously made available by the authors may be considered legitimate when properly identified, cited, and compatible with good editorial practices. Cases of possible plagiarism, inappropriate self-plagiarism, redundant duplication, inappropriate fragmentation of results, or absence of proper attribution will be evaluated by the editors, who may request clarifications, corrections, text revision, or additional documentation before making an editorial decision. The analysis will consider the scientific and ethical context of the manuscript, not only numerical similarity indicators. Copyright authorization: when submitting the manuscript for the RPPed evaluation process, all authors must sign the form available on the submission website, in which the authors acknowledge that, from the moment of acceptance of the article for publication, the author maintains the copyright over the published article and the Associação de Pediatria de São Paulo holds the right of first publication. Articles are published under the Creative Commons Attribution 4.0 International license (CC BY 4.0), with copyright remaining with the authors. All mandatory documents are available at: https://www.spsp.org.br/publicacoes/revista/ All mandatory documents are available at: https://www.spsp.org.br/publicacoes/revista/ |
Digital Assets
Tables, figures, charts, flowcharts, and other illustrations A combined total of up to 6 digital assets per article is allowed, including tables, figures, graphs, flow diagrams, and other illustrations. These items must be submitted in the same file as the article and placed at the end, after the references. The participant flow diagram is mandatory for clinical trials, cohort studies, and case-control studies, and counts toward the combined digital asset limit. If approved, higher-resolution figures and graphs may be requested. Tables Tables must be typed in a minimum font size of 11. To avoid horizontal tables, RPPed recommends that authors use a maximum of 100 characters per table line. The combined set of tables, figures, graphs, and other illustrations must respect the limit of up to 6 digital assets per article. Explanations should appear in table footnotes and not in the title. Do not use any space next to the ± symbol. Type tables in Microsoft Word using rows and columns; do not separate columns with tab marks. Do not import tables from Microsoft Excel or Microsoft PowerPoint. Numerals in tables: when numbers are integers, use a maximum of one decimal place. For decimal numbers, preferably use two decimal places. For p-values, use 3 decimal places. To report odds ratios or relative risks and confidence intervals, use 2 decimal places. Graphs and charts Number graphs according to the order in which they appear in the text and place a title below them. Graphs must be two-dimensional and may use colors, provided that they remain legible in print or grayscale versions. They may be created in Microsoft Excel, PowerPoint, or other appropriate software for creating graphs and images, except for artificial intelligence tools. At submission, insert graphs in the text at the end, together with the captions. In addition, submit graphs as a separate file in editable or high-resolution format. RPPed does not accept scanned graphs or graphs generated by artificial intelligence (AI). Figures Figures must be numbered in the order in which they appear in the text. Explanations must appear in the caption. Figures reproduced from other sources must indicate this condition in the caption and have written permission from the source for reproduction. Obtaining permission to reproduce images is the sole responsibility of the author. Patient photographs must not allow identification of the individual; if identification is possible, a consent letter signed by the photographed individual or their guardian authorizing dissemination of the material is mandatory. Figures may be created in software appropriate for image creation or editing, provided they do not use artificial intelligence (AI) tools. Figures should not be created directly using Microsoft Word drawing tools, because these elements often undergo positioning and formatting changes during editing, review, layout, and file conversion. Flow diagrams, schemes, illustrations, and composite figures should be created in more appropriate programs, such as Microsoft PowerPoint, and then exported or copied as static images, such as .png, .tif, or .jpg, for insertion in the manuscript. At submission, insert figures in the text at the end, together with the captions. In addition, submit figures as a separate file in editable or high-resolution format. Computer-generated images must be attached in .jpg, .gif, .tif, .eps, or .pdf formats, with minimum resolution of:
RPPed does not accept scanned figures or figures generated by artificial intelligence (AI). Contrast adjustments, background removal, or software with embedded AI features are permitted when explicitly declared and when they do not alter the scientific content of the image. |
Citations and References
REFERENCES RPPed encourages the use of reference management software and, when appropriate, artificial intelligence tools to support the organization, formatting, and initial checking of citations and references. However, all references must be manually checked by the authors before submission, including authorship, title, journal or source, year, volume, pages, DOI, identifiers, and correspondence between in-text citations and items in the final list. RPPed adopts Vancouver style, according to ICMJE recommendations and examples from the National Library of Medicine. References must be numbered consecutively in the order in which they appear in the text, and the final list must follow the same numerical order.
1. Preprints: if the manuscript was published in a preprint repository it must be cited in the references Li X, Lidsky P, Xiao Y, Wu CT, Garcia-Knight M, Yang J, et al. Ethacridine inhibits SARS-CoV-2 by inactivating viral particles in cellular models. BioRxiv [Preprint]. 2020 Nov 2:2020.10.28.359042. doi: 10.1101/2020.10.28.359042. 2. Articles in periodicals Up to 6 authors: list all authors: Jih WK, Lett SM, des Vignes FN, Garrison KM, Sipe PL, Marchant CD. The increasing incidence of pertussis in Massachusetts adolescents and adults, 1989-1998. Infect Dis. 2000;182:1409-16. More than 6 authors: Rose ME, Huerbin MB, Melick J, Marion DW, Palmer AM, Schiding JK, et al. Regulation of interstitial excitatory amino acid concentrations after cortical contusion injury. Brain Res. 2002;935:40-6. Research groups: a. No defined author: Diabetes Prevention Program Research Group. Hypertension, insulin, and proinsulin in participants with impaired glucose tolerance. Hypertension. 2002;40:679-86. b. With defined author: Vallancien G, Emberton M, Harving N, van Moorselaar RJ; Alf-One Study Group. Sexual dysfunction in 1,274 European men suffering from lower urinary tract symptoms. J Urol. 2003;169:2257-61. c. No authors: No-referred authorship. 21st century heart solution may have a sting in the tail. BMJ. 2002;325:184. Volume with supplement: Geraud G, Spierings EL, Keywood C. Tolerability and safety of frovatriptan with short- and long-term use for treatment of migraine and in comparison with sumatriptan. Headache. 2002;42 Suppl2:S93-9. Article published electronically, before the printed version: Yu WM, Hawley TS, Hawley RG, Qu CK. Immortalization of yolk sac-derived precursor cells. Blood; Epub 2002 Jul 5. Articles accepted for publication still in press: Tian D, Araki H, Stahl E, Bergelson J, Kreitman M. Signature of balancing selection in Arabidopsis. Proc Natl Acad Sci USA. In press 2002. 3. Books and other monographs - Books: Gilstrap LC 3rd, Cunningham FG, Van Dorsten JP. Operative obstetrics. 2nd ed. New York: McGraw-Hill; 2002. Note: If it is the 1st edition, it is not necessary to cite the edition. 4. Book chapters: Meltzer PS, Kallioniemi A, Trent JM. Chromosome alterations in human solid tumors. In: Vogelstein B, Kinzler KW, editors. The genetic basis of human cancer. 2nd ed. New York: McGrawHill; 2002. p. 93-113. Note: If it is the 1st edition, it is not necessary to cite the edition. 5. Conference published in Congress annals: Christensen S, Oppacher F. An analysis of Koza’s computational effort statistic for genetic programming. Proceedings of the 5th European Conference on Genetic Programming; 2002 Apr 3-5; Kinsdale, Irlanda. p. 182-91. 6. Abstracts published in conference proceedings: Blank D, Grassi PR, Schlindwein RS, Melo JL, Eckhert GE. The growing threat of injury and violence against youths in southern Brazil: a ten year analysis. Abstracts of the Second World Conference on Injury Control; 1993 May 20-23; Atlanta, USA. p. 137-8. 7. Master's or doctoral theses: Afiune JY. Avaliação ecocardiográfica evolutiva de recém-nascidos pré-termo, do nascimento até o termo [master´s thesis]. São Paulo (SP): USP; 2000. 8. Other published materials: Artigos em jornais, boletins e outros meios de divulgação escrita: Tynan T. Medical improvements lower homicide rate: study sees drop in assault rate. The Washington Post. 2002 Aug 12. p.1. 9. Laws, ordinances and recommendations: Brazil - Ministério da Saúde. Recursos humanos e material mínimo para assistência ao RN na sala de parto. Portaria SAS/MS 96, 1994. Institui diretrizes para a organização da atenção integral e humanizada ao recémnascido (RN) no Sistema Único de Saúde (SUS). Brasília (DF): Diário Oficial da União, 1994. Note: If the material is available online, place Available from: htttp://www.... 10. Electronic material - Electronic periodical article: Abood S. Quality improvement initiative in nursing homes: the ANA acts in an advisory role. Am J Nurs [serial on the Internet]. 2002;102 [cited 2002 Aug 12]. Available from: http://www.nursingworld.org/AJN/2002/ june/Wawatch.htm 11. Monograph on the internet or electronic book: Foley KM, Gelband H. Improving palliative care for cancer [homepage on the Internet]. Washington: National Academy Press; 2001 [cited 2002 Jul 9]. Available from: http://www. nap.edu/books/0309074029/html/ 12. Homepage/website: Cancer-Pain.org [homepage on the Internet]. New York: Association of Cancer Online Resources [cited 2002 Jul 9]. Available from: http://www.cancer-pain.org/. 13. Part of a homepage or website: American Medical Association [homepage on the Internet]. AMA Office of Group Practice Liaison [cited 2002 Aug 12]. Available from: http://www.ama-assn.org/ama/pub/cate- gory/1736.html Note: Personal communications should not be cited as references. |
Supplementary Documents
Supplementary documents and materials must be submitted separately from the manuscript file when they are necessary for editorial evaluation. There is no predefined limit to the amount of supplementary material, provided that its use is justified and the files are organized, identified, and referred to in the manuscript. RPPed does not host or publish supplementary materials; when relevant, these should be made available to readers by the authors themselves, preferably through appropriate repositories or upon request to the corresponding author. Mandatory supplementary documents must be prepared according to the available templates: |
Financing Statement
Describe whether the work received financial support, the source in full, the country, and the grant or process number. Do not repeat support in acknowledgments. All sponsors must be mentioned, whether there was financial or other support. This information must appear on the Title Page. |
Additional Information
The complete content of the original article must comply with the “Uniform Requirements for Originals Submitted to Biomedical Journals”, published by the International Committee of Medical Journal Editors. |
Contact
Sociedade de Pediatria de São Paulo
|
Read our Open Access Statement